Skip to content

Clinical trials

Completed Hyperlipidemias trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Status: Completed Country / region: Czechia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20061
20111
20121
20134
20141
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Pfizer3
Takeda3
Solvay Pharmaceuticals2
89bio, Inc.1
AstraZeneca1
Genentech, Inc.1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias16
Hypercholesterolemia6
Dyslipidemias3
Hypertriglyceridemia2
Metabolic Diseases2
Coronary Disease1
Diabetes Mellitus, Type 21
Hyperlipoproteinemia Type II1
Lipid Metabolism Disorders1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.